Incyte Corporation (INCY)
Solvency ratios
| Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial leverage ratio | 1.58 | 1.58 | 1.32 | 1.31 | 1.30 | 1.31 | 1.30 | 1.34 | 1.30 | 1.30 | 1.31 | 1.31 | 1.33 | 1.33 | 1.34 | 1.36 | 1.38 | 1.37 | 1.42 | 1.32 |
Incyte Corporation consistently maintains a strong solvency position based on its solvency ratios. The Debt-to-assets ratio, Debt-to-capital ratio, and Debt-to-equity ratio have all remained at 0.00 across various reporting periods, indicating zero debt in relation to the company's assets, capital, and equity. This signifies that Incyte is not heavily reliant on borrowed funds to finance its operations.
The Financial leverage ratio, which stood at 1.32 as of December 31, 2019, has shown slight fluctuations over the reporting periods but generally remains relatively stable, indicating a moderate level of financial leverage. The increase in the Financial leverage ratio to 1.58 as of December 31, 2024, may indicate a slightly higher reliance on debt financing, which investors and creditors would need to monitor to ensure it does not pose a risk to the company's financial health.
Overall, Incyte Corporation's solvency ratios suggest a prudent financial management approach with a low level of debt and reasonable leverage, supporting the company's ability to meet its financial obligations and sustain long-term growth.
Coverage ratios
| Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest coverage | 393.88 | 337.84 | 406.46 | 328.01 | 267.72 | 230.71 | 208.92 | 199.47 | 207.66 | 247.92 | 257.46 | 299.97 | 391.48 | 241.11 | 281.26 | -105.81 | -115.58 | -50.05 | -150.45 | 263.42 |
The interest coverage ratio of Incyte Corporation has shown fluctuations over the period from December 31, 2019, to December 31, 2024. The ratio indicates the company's ability to meet its interest obligations with its operating income. A higher interest coverage ratio is generally considered favorable as it suggests a stronger ability to cover interest expenses.
From December 31, 2019, to June 30, 2020, the interest coverage ratio was negative, indicating that the operating income was insufficient to cover interest payments during those periods. This may raise concerns about the company's ability to service its debt obligations with its current level of earnings.
However, from March 31, 2021, to December 31, 2024, the interest coverage ratio improved significantly, reaching levels well above 1, which suggests a strong ability to cover interest expenses with operating income. This improvement indicates a more stable financial position and increased profitability for Incyte Corporation during these periods.
Overall, the trend in Incyte Corporation's interest coverage ratio shows variability but generally indicates an improvement in the company's ability to cover its interest expenses with operating income over the analyzed period.